Dergiler / Turkish archives of pediatrics (Online) / 2022 / Cilt: 57 - Sayı: 2

Hepatitis A Vaccine Effectiveness and Seropositivity Among 1- to 18-Year-Old Children: 10-Year Results

Sayfa
205–509
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

This study is the most comprehensive report of hepatitis A seropositivity in Turkey to date

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: The aim of the study was to examine and compare hepatitis A seropositivity in children.
📊
Temel Bulgular & Veri:Materials and Methods: The study included patients aged 0-18 years who presented to our hos- pital and were examined for hepatitis A virus serology between 2009 and 2018.
💡
Sonuç & Katkı:This study is the most comprehensive report of hepatitis A seropositivity in Turkey to date
🔬Tür:Araştırma Makalesi
📍Kapsam:2009 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objective: The aim of the study was to examine and compare hepatitis A seropositivity in children. Materials and Methods: The study included patients aged 0-18 years who presented to our hos- pital and were examined for hepatitis A virus serology between 2009 and 2018. Patients were separated into 2 groups: those who presented before (group I) or after (group II) September 2012, when the mandatory hepatitis A vaccination program came into effect in Turkey. Results: In total, 34 809 patients were evaluated: 20 111 (57.8%) males and 14 698 (42.2%) females, with a mean age of 8.2 ± 5.3 years. Anti-hepatitis A virus immunoglobulin M positiv- ity was observed in 3.3% of patients, most often in January and from January to April when the region experiences more rainfall. Anti-hepatitis A virus immunoglobulin M positivity decreased dramatically in group II compared to group I (0.26% vs. 7.42%, P < .001). Anti-hepatitis A virus immunoglobulin G positivity was observed in 53.8% of all patients. A statistically significant increase was determined in anti-hepatitis A virus immunoglobulin G seropositivity in group II compared to group I (81.9% vs. 42.1%, P < .001). Conclusion: Hepatitis A virus infection in Turkey decreased dramatically following improve- ments to infrastructure and sanitation and implementation of the vaccination program. This study is the most comprehensive report of hepatitis A seropositivity in Turkey to date

🔖

Bu Makaleye Atıf Yap

SAMANCI, S., AKDENİZ, O. (2022). Hepatitis A Vaccine Effectiveness and Seropositivity Among 1- to 18-Year-Old Children: 10-Year Results. Turkish archives of pediatrics (Online), Cilt: 57 - Sayı: 2, 205–509. https://ajindex.com/articles/418317

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (10)

  1. Leung AK, Kellner JD, Davies HD. Hepatitis A: a preventablethreat. Advther. 2005;22:578-586
  2. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653-6657. [CrossRef] 3. World Health Organization (WHO). The immunological basis for immunization series: module 18: hepatitis A. Geneva, Switzerland: World Health Organization; 2019. Available at: https://ww w.who.int/ immun izati on/do cumen ts/IS BN 978-92-51632-7/en/
  3. Andani A, van Elten TM, Bunge EM, Marano C, Salgado F, Jacob- sen KH. Hepatitis A epidemiology in Latin American countries: a 2020 viewfrom a systematic literature review. Expert Rev Vaccines. 2020;19(9):795-805. [CrossRef] 5. Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor- countries. Curr Opin Infect Dis. 2015;28(5):488-496. [CrossRef] 6. Yılmaz A. Hepatitis A seroprevalence in Erzurum, Turkey. Ann Agric Environ Med. 2020;27(3):481-484. [CrossRef]
  4. Bell BP, Anderson DA, Feınstone SM. Hepatitis A. In: Virüs, Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005:2162-2184
  5. Yassin K, Awad R, Tebi A, Queder A, Lasser U. Theepidemiology of hepatitis A infection in Paletsine: a universalvaccinationpro- gramme is not yet needed. Epidemiolinfect. 2001;127:335-339
  6. Arabacı F, Oldacay M. The seroprevalance of hepatitis A in differ- ent age groups and hepatitis A incidence in acute hepatitis cases in the Canakkale province. J Pediatr Inf. 2009;3:58-61
  7. Ceran N, Kocdogan FY, Mert D, et al. Hepatitis A seroprevalence in childrenandyoungadults in Istanbul, Turkey: seroprevalence change and associated factors. Viralhepat J. 2012;19:72-76
  8. Dede A, Calıskan E, Guven GB, Cizmeci Z. Hepatitis A seropositivity in outpatients at Keçiören Teaching and Research Hospital. Viral- hepat J. 2013;19:163-164
  9. Cortes-Martins H, Matos R, Moura S, et al. Anti-HAV IgG sero- prevalence in Lisbon region residents: preliminary results from the National Serological Survey 2015-2016. J Clinvirol. 2016;82:79-80
  10. Vilibic-Cavlek T, Kucinar J, Ljubin-Sternak S, Kolaric B. Seroepide- miology of hepatitis A in thecroatianpopulation. Hepat Mon. 2011;11(12):997-999. [CrossRef] 14. Arvas G, Kaya B, Berktaş M. The seroprevalance of acute hepatitis A in 0-18 age group children who applied to Igdır State Hospital. J Pediatr Inf. 2011;5(4):129-131. [CrossRef] 15. Parlak M, Çıkman A, Güdücüoğlu H,